Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
- PMID: 29607374
- PMCID: PMC5863423
- DOI: 10.4103/apjon.apjon_79_17
Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents
Abstract
Today, personalized cancer therapy with targeted agents has taken center stage, and offers individualized treatment to many. As the mysteries of the genes in a cell's DNA and their specific proteins are defined, advances in the understanding of cancer gene mutations and how cancer evades the immune system have been made. This article provides a basic and simplified understanding of the available (Food and Drug Administration- approved) molecularly and immunologically targeted agents in the USA. Other agents may be available in Asia, and throughout the USA and the world, many more agents are being studied. Nursing implications for drug classes are reviewed.
Keywords: Cancer; immunological; molecular; targeted agents; targeted therapy.
Conflict of interest statement
There are no conflicts of interest.
References
-
- World Health Association. Cancer Fact Sheet. February. 2017. [Last accessed on 2017 Nov 27]. Available from: http://www.who.int/mediacentre/factsheets/fs297/en/
-
- American Cancer Society. Global Cancer Facts and Figures 3rd ed. American Cancer Society. 2015. [Last retrieved on 2017 Oct 20; Last accessed on 2017 Nov 27]. Available from: https://www.cancer-org/content/dam/cancer.org/research/cancer-facts-and-... .
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144:646–74. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
